Institution statistics

FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III - Spain 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:> 1000
Total Number of Projects:800-900
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:500-600
Total Number of Projects:> 1000
Networking Rank (Reputation):800-900
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:100-200
Total Number of Projects:400-500
Networking Rank (Reputation):600-700
Partner Constancy:800-900
Project Leadership Index:600-700
2012
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:600-700
Total Number of Projects:67
Total Project Funding:500-600
Networking Rank (Reputation):700-800
Networking Rank (Reputation):700-800
Partner Constancy:46
Project Leadership Index:75
Diversity Index:37
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:200-300
Total Number of Projects:800-900
Total Project Funding:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:48
Total Number of Projects:200-300
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Partner Constancy:> 1000
Project Leadership Index:60
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:300-400
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:600-700
2007
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Total Project Funding:100-200
Networking Rank (Reputation):400-500
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 47
As coordinator: 3
As participant: 30
Sole participant: 14
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 160.932 8.236.379 947.582 1 1
2020 7.051.780 0 7.051.780 4
2019 0 20.092.744 1.695.717 4
2018 158.122 2.499.875 158.122 1 1
2017 170.122 0 170.122 1
2016 0 8.960.273 1.935.032 2
2015 4.488.850 36.753.230 5.192.684 2 5
2014 100.000 1.997.819 2.097.819 1 1
2013 100.000 14.622.363 734.187 1 3
2012 226.548 22.486.405 1.608.399 1 3
2011 3.458.206 66.785.072 5.016.283 4 7
2010 161.900 24.693.589 3.603.471 1 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
EUROPEAN MOLECULAR BIOLOGY LABORATORY7
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE5
ISTITUTO EUROPEO DI ONCOLOGIA5
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS4
INSTITUT CURIE4
KAROLINSKA INSTITUTE4
STICHTING KATHOLIEKE UNIVERSITEIT4
UNIVERSITAET ULM4
UNIVERSITY OF COPENHAGEN4
WEIZMANN INSTITUTE OF SCIENCE4
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION3
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS3
INSTITUT GUSTAVE ROUSSY3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
INSTITUT PASTEUR3
KATHOLIEKE UNIVERSITEIT LEUVEN3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
PHILIPPS UNIVERSITAET MARBURG3
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE3
THE UNIVERSITY OF MANCHESTER3
UNIVERSITY COLLEGE LONDON3
ACADEMISCH ZIEKENHUIS GRONINGEN2
ACADEMISCH ZIEKENHUIS LEIDEN2
CANCER RESEARCH UK2
CELLZOME2
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN2
CONCENTRIS RESEARCH MANAGEMENT2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
FUNDACIO PRIVADA PARC CIENTIFIC DE BARCELONA2
FUNDACION IMDEA NANOCIENCIA2
GENOME RESEARCH2
HOSPITAL UNIVERSITARIO DE FUENLABRADA2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE2
KAROLINSKA INSTITUTET2
KING'S COLLEGE LONDON2
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN2
LEIDEN UNIVERSITY MEDICAL CENTER2
LUNDS UNIVERSITET2
MEDICAL RESEARCH COUNCIL2
OSLO UNIVERSITETSSYKEHUS HF2
REGION HOVEDSTADEN2
SECONDA UNIVERSITA DEGLI STUDI DI NAPOLI2
SERVICIO MADRILENO DE SALUD2
TARTU ULIKOOL2
TECHNISCHE UNIVERSITAET MUENCHEN2
THE PROVOST FELLOWS FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN2
THE UNIVERSITY OF EDINBURGH2
THE UNIVERSITY OF LIVERPOOL2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITA DEGLI STUDI DI VERONA2
UNIVERSITAET BERN2
UNIVERSITAET LEIPZIG2
UNIVERSITAET ZUERICH2
UNIVERSITAETSKLINIKUM ESSEN2
UNIVERSITE DE GENEVE2
UNIVERSITY OF BERGEN2
UNIVERSITY OF MELBOURNE2
UNIVERZA V LJUBLJANI2
UPPSALA UNIVERSITET2
VIB2
VTT TECHNICAL RESEARCH CENTRE OF FINLAND2
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
AGILENT TECHNOLOGIES OESTERREICH1
AGROKNOW IKE1
AMIRES SRO1
ANAXOMICS BIOTECH S L1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ATHENA RESEARCH AND INNOVATION CENTER IN INFORMATION COMMUNICATION & KNOWLEDGE TECHNOLOGIES1
ATHINAEREVNITIKO KENTRO KAINOTOMIAS STIS TECHNOLOGIES TIS PLIROFORIAS TON EPIKOINONION KAI TIS GNOSIS1
ATLAS BIOLABS1
ATOS SPAIN1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
AXCENTUA PHARMACEUTICALS AB1
BAYER1
BAYER PHARMA1
BAYER SCHWEIZ1
BIOKERALTY RESEARCH INSTITUTE AIE1
BIOMAX INFORMATICS1
BIOMEDCODE ELLAS ANONIMI ETERIA EPISTIMONIKIS KAI TEXNOLOGIKIS EREVNASKAI EMBORIKIS EKMETALLEFSIS EPHARMOGON IATRIKIS1
BIOMEDICAL RESEARCH FOUNDATION ACADEMY OF ATHENS1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
BIOPRODICT BV1
CARL ZEISS MICROSCOPY1
CEGAT1
CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LEDEVELOPPEMENT CIRAD EPIC1
CENTRE DE REGULACIO GENOMICA1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRO DE CIENCIAS DO MAR DO ALGARVE1
CESNET ZAJMOVE SDRUZENI PRAVNICKYCH OSOB1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHEMICELL1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
Constancy:

Total number of partners:383

Partner loyalty:
Frequent Partner: (> 2 projects): 93
Rare Partner: 290

Frequent / Rare Partner Ratio: 0.32

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES17
RTD HORIZONTAL TOPICS7
SOCIAL AND ECONOMIC CONCERNS4
ENERGY1
INDUSTRY AND TECHNOLOGY1
AGRICULTURE AND MARINE RESOURC1
PHYSICAL AND EXACT SCIENCES1

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Tumor compartment-specific effects of P70S6K in early triple negative breast cancer: regulation of antitumor immune response and therapeutic implications P70-IMMUNEBREASTcoordinator160.9321
2021-01-01Pancreatic cancer AI for genomics and personalized Medicine PANCAIMparticipant8.236.3799
2020-12-01Imaging, characterizing and targeting metastatic niches in melanoma METALERT-STOPcoordinator2.497.9451
2020-09-01Super-enhancer modules controlling plasticity and response to therapy in pancreatic cancer PDASwITchcoordinator160.9321
2020-07-01Metastasis-associated altered molecular patterns in the brain ALTER-braincoordinator1.897.4371
2020-07-01Targeting Shelterin Proteins in Cancer SHELTERINScoordinator2.495.4661
2019-10-01The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance proEVLifeCycleparticipant2.672.56210
2019-09-01Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine TranSYSparticipant3.937.79913
2019-05-01BRInGing nano-pHoTonics into the brain NanoBRIGHTparticipant3.496.1984
2019-01-01European Proteomics Infrastructure Consortium providing Access EPIC-XSparticipant9.986.18618
2018-10-01METLINK: Identification of links between cancer cell growth and metabolism genes. METLINKcoordinator158.1222
2018-06-01Chronic Systemic Inflammation: Functional organ cross-talk in inflammatory disease and cancer CSI-Funparticipant2.499.8752
2017-04-01Long range-acting drivers of premetastatic niches in melanoma METMELcoordinator170.1221
2016-04-01Nanomedicine upscaling for early clinical phases of multimodal cancer therapy NoCanTherparticipant7.113.77912
2016-01-01The Physiology of Nutrient Sensing by mTOR NutrientSensingVivoparticipant1.846.4941
2015-12-01Training Network for the Immunotherapy of Cancer IMMUTRAINparticipant3.627.52510
2015-11-01Global dynamics of topoisomerase-induced DNA breaks TOPOmicscoordinator2.000.0002
2015-10-01New Frontiers in Cellular Reprogramming: Exploiting Cellular Plasticity CELLPLASTICITYcoordinator2.488.8501
2015-10-01Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment AVATARparticipant2.498.6882
2015-09-01Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES) BRIDGESparticipant6.200.00018
2015-09-01ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences. ELIXIR-EXCELERATEparticipant19.051.48248
2015-06-01Open Mining INfrastructure for TExt and Data OpenMinTeDparticipant5.375.53616
2014-07-01DNA Damage Response (DDR) signaling in tumor formation and therapeutic resistance of gliomas GLIDDcoordinator100.0001
2014-03-01Investigating the causes and consequences of replication stress in mammalian health RSHEALTHparticipant1.997.8191
2013-11-01Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer CAM-PACparticipant11.193.10814
2013-09-01Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction TRANSBIOBCparticipant3.260.3594
2013-07-01Bioinformatics and Integrative Genomics for a Novel Personalized Cancer Therapy PERSMEDOMICScoordinator100.0001
2013-03-01Improving the selectivity of kinase inhibitors: Characterizing binding mechanisms of inhibitors targeting inactive states and allosteric sites KIBINDINGparticipant168.8962
2012-11-01"RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research" RD-CONNECTparticipant11.997.11127
2012-11-01"Risk, Stem Cells and Tissue Kinetics – Ionising Radiation" RISK - IRparticipant6.685.00012
2012-10-01Joint training and research network on Chromatin Dynamics and the DNA Damage Response ADDRESSparticipant3.804.29410
2012-09-01Role of the protein kinase Mastl in Cell Division and Cancer Mastl CDCcoordinator226.5481
2011-10-01Clonal analysis in pancreatic development, differentiation and carcinogenesis PanCloncoordinator230.9801
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2011-07-01Rational designing of new meganucleases as molecular scissors for genomic tailoring SMARTBREAKERcoordinator75.0001
2011-06-13Multifunctional Nanotechnology for selective detection and Treatment of cancer MULTIFUNparticipant9.799.99417
2011-04-01Safer gene repair and targeting based on the monomeric meganuclease I-DmoI by design of homologous-recombination-inducing nickase activity DmoNickaseDesigncoordinator155.4171
2011-04-01Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours CANCERALIAcoordinator2.996.8097
2011-02-01Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-Netparticipant3.000.00017
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2011-01-01European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults ENS@T-CANCERparticipant5.993.97816
2011-01-01New approaches for the targeted therapy of Non-Small Cell Lung Cancer LUNGTARGETparticipant2.997.33210
2011-01-01Identifying biomarkers of ageing using whole transcriptomic sequencing EuroBATSparticipant2.998.6505
2010-11-01ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours ASSETparticipant11.999.15619
2010-06-01Systems Biology of Mitosis MitoSysparticipant10.198.24114
2010-04-01Ras Genes in Health and Disease RAS AHEADparticipant2.496.1921
2010-03-01The role of activation-induced cytidine deaminase in inflammation-induced carcinogenesis InflAIDCancoordinator161.9001

Alias institution names:
  • FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum